TD Cowen analyst Tara Bancroft maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price target of ...

On Friday, TD Cowen's Bryan Bergin slapped a new 12-month price target on Mastercard of $567 per share, well up from his ...

TD Cowen analyst Andrew Sherman named Datadog (DDOG) a Best Idea for 2025 while keeping a Buy rating on the shares with a $165 price target ...

John Kernan, TD Cowen managing director and retail analyst, joins 'Money Movers' to discuss how important Chinese exposure is ...

Uncertainty about how US President-elect Donald Trump will apply tariffs has prompted an analyst at Toronto-Dominion Bank to ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.19% of ...

On Friday, Xylem Inc (XYL) stock saw a modest uptick, ending the day at $121.78 which represents a slight increase of $0.15 or 0.12% from the prior close of $121.63. The stock opened at $121.73 and ...

Life Science Tools and Diagnostics stocks are viewed favorably at TD Cowen despite concerns over Trump's policies and his HHS ...

We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...